Table 1.
Characteristics of the study population: Tehran Lipid and Glucose Study
| Characteristic | MetS | T2DM | ||
|---|---|---|---|---|
| No (n = 720) | Yes (n = 438) | No (n = 924) | Yes (n = 139) | |
| Age (y) | 40.8 ± 12.9 | 52.1 ± 12.8* | 44.3 ± 13.1 | 55.9 ± 11.7* |
| Female (%) | 58.1% | 47.5%* | 54.4% | 49.6% |
| Body mass index (kg/m2) | 26.3 ± 4.56 | 30.4 ± 4.51* | 27.8 ± 4.85 | 30.3 ± 5.10* |
| Waist circumference (cm) | 89.3 ± 11.4 | 101 ± 9.54* | 93.4 ± 11.8 | 101.1 ± 10.7* |
| SBP (mmHg) | 108 ± 14.1 | 122 ± 16.1* | 112 ± 15.7 | 123 ± 17.2* |
| DBP (mmHg) | 73.8 ± 9.28 | 80.7 ± 9.54* | 75.9 ± 10.1 | 79.8 ± 9.21* |
| TG/HDL ratio | 2.35 ± 1.71 | 5.36 ± 4.34* | 3.36 ± 3.00 | 4.89 ± 5.08* |
| Serum LDL-C (mg/dL) | 110 ± 30.8 | 109 ± 35.7 | 111 ± 31.7 | 105 ± 39.1* |
| Serum creatinine (mg/dL) | 1.07 ± 0.15 | 1.14 ± 0.17* | 1.09 ± 0.16 | 1.15 ± 0.19* |
| eGFR (mL/min per 1.73m2) | 75.6 ± 12.2 | 66.8 ± 13.2* | 73.0 ± 12.5 | 64.3 ± 13.4* |
| Urinary microalbumin (mg/L) | 14.1 ± 30.3 | 19.9 ± 45.9* | 13.1 ± 25.8 | 35.3 ± 72.9* |
| Urinary creatinine (mg/L) | 1580 ± 701 | 1537 ± 725 | 1587 ± 717 | 1417 ± 668* |
| Microalbumin to creatinine ratio (mg/mg) | 0.011 ± 0.030 | 0.018 ± 0.057* | 0.010 ± 0.026 | 0.036 ± 0.096* |
| Microalbuminuria (%) | 12.8% | 16.7%* | 12.8% | 19.4%* |
MetS metabolic syndrome, T2DM type 2 diabetes mellitus, SBP systolic blood pressure, DBP diastolic blood pressure, TG triglyceride, HDL-C high density lipoprotein-cholesterol, LDL-C low density lipoprotein-cholesterol, eGFR estimated glomerular filtration rate
Values are expressed as mean ± SD
* P value < 0.05